Anilyze is a stealth-mode startup leading the transition to secure animal health data management for all stakeholders in the industry. We use proprietary hardware and software to improve traceability and accountability, bringing humans and animals closer together. All while driving advancements in both animal welfare and public health.

Palance is on a mission to revolutionise investment portfolio analytics, offering a groundbreaking platform that addresses the widespread challenges faced by both individual and business investors. Our comprehensive solution combines extensive benchmarks, global coverage exceeding 100,000 listings, precise risk calculations tailored for ETFs and Mutual Funds, an intuitive user interface, and potentially game-changing AI/ML features (subject to funding). In a landscape dominated by limited access and high costs, Palance is committed to democratising sophisticated analytics tools, providing unparalleled affordability advantages. Our journey began with a passion for empowering investors of all sizes, fueled by the recognition of the crucial need for accessible, user-friendly, and powerful investment analytics. Through Palance, we strive to not only enhance portfolio performance and efficiency but also transform the way investors make informed decisions, making a lasting impact on the investment landscape!

Neucom builds ultra-efficient hardware accelerators that combine minimal power consumption with maximum human oversight. We work towards a freer and fairer world with trustworthy technology, one chip at the time. Our hardware is informed by neuroscience to achieve minimal power consumption. Our headquarter is in Lyngby, just north of Copenhagen Denmark.

As the world pushes to limit global warming, energy remains one of the hardest industries to trace, even though it accounts for 73% of global carbon emissions. Traditional tracking systems rely on basic, annual certificates that lack the detail and transparency needed to drive meaningful change. Companies spend over €24.4 billion annually on these outdated certificates, facing high costs and uncertainty—obstacles that slow down progress toward carbon neutrality. At Spritju, we're changing that. Our B2B marketplace for energy certificates empowers companies to cut costs by 20% and track their energy use with precision, offering certificates with 8,760 times the granularity. By joining Spritju, you’ll play a hands-on role in shaping a more transparent, sustainable energy landscape. Your work will contribute to a future where companies can confidently reduce their carbon footprint, moving us all closer to a sustainable and accountable energy future.

Hera Solutions is an early-stage startup developing technology within the transportation and logistics sector. We are developing a robust and secure system for the electronic transmission of shipping information, through our first product Hera Road. We offer a driver application and administration panel to transport companies for a real-time overview of goods during transport, which simplifies communication, handling and documentation of tasks carried out. As a young company, flexibility is important to us, we always start with the end user, are adaptable, and deliver value immediately. We are an innovative company with big ambitions to scale internationally in a few years. By taking part in Hera Solutions, you will have the opportunity to take part in an incredibly demanding and exciting phase of the company's development.

Founded in Switzerland with creative roots in Finland and Portugal, Paloceras is an independent eyewear house known for crafting frames that explore the space between what is visible and what is felt. As praised by Vogue, ELLE, Grazia, and Elite Daily, each creation blends digital precision with hand-finished craftsmanship and draws on a rich visual language shaped by nature, memory, and quiet rebellion. Paloceras is available in select boutiques, online at paloceras.com, and on socials at @paloceras.

Problem: Denmark faces a significant challenge with over 500,000 chronic heart patients who find themselves trapped in a cycle of frequent healthcare visits, averaging 16 times more visits per quarter compared to regular patients. This problem stems from a lack of comprehensive insight into patients' health due to inadequate consumption and continuous monitoring of biometric datasets. Consequently, patients resort to frequent hospital visits to compensate for this lack of insight, placing a substantial burden on medical facilities, clinicians, ethics, and patient well-being during these 'chronic cycles.' Vision: Our vision aims to optimize the current monitoring and care paradigm for chronic heart patients by providing detailed and long-term insights into patients biometric datasets. We intend to achieve this vision through the development and advancement of our product, 'The Link,' a patient-friendly Med-Tech wearable. 'The Link' simplifies user interaction with its recognizable design while maintaining clinical accuracy through 12-lead ECG and supplemented sensors.

GreenWeb. is the first data-driven calculation engine for estimating the climate impact of websites. Using comprehensive data scopes involving website traffic, energy intensity of web data and real-time carbon intensity of the electricity grid, GreenWeb. offers members to climate neutralize their web solutions and actively assist in reducing the footprint of the site.

We help businesses add human faces to real-time AI chatbots, assistants and agents. Our customers typically build AI tutors, AI receptionists, AI coaches, AI mock interviews, AI employee onboarding, you get the picture! Try talking to a human avatar here: https://www.simli.com/demo Our Docs: https://docs.simli.com/introduction Discord: https://discord.com/invite/yQx49zNF4d

Household targeting & measurement for the post-cookie world. Digiseg maps digital advertising to household characteristics. Our cookie and tracking free technology can be used across all devices, media types and operating systems – including iOS - to target advertising and measure audiences for both campaigns and websites.

IZX is a platform for integrating LLMs into business applications, enabling natural language understanding and automation. Our product streamlines the creation, inference, and scaling of enterprise foundational models (that can also be hosted on-premise or in private cloud) that interact with external LLMs, APIs, and data sources. Our team includes the top 1% of AI/ML engineers in Europe. Join our team!

Velocity capital works with visionary companies building for sustainable growth. Founded by Allan Sønderskov Darré, Velocity brings capital and expertise from day zero to IPO. Every day our team works closely with our portfolio companies, which consists of a wide range of businesses across industries and growth stages.

Synexa Life Sciences has established its position as a leading specialist in clinical biomarker stratification and bioanalysis. For over 20 years, Synexa Life Sciences has supported large and emerging biopharma customers across the globe to achieve their clinical milestones through the delivery of cutting-edge biomarker and bioanalytical services. Synexa specializes in the development, validation and delivery of a wide range of complex and custom-designed assays across five laboratory locations. Synexa Life Sciences’ guiding principles are reflected in our collaborative approach to providing customized, flexible solutions to meet our customers specific needs. We pride ourselves on our scientific know how and our ability to partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa is a privately held company, backed by Gilde Healthcare, a specialized European healthcare investor. Synexa is led by a growing team of industry experts and highly experienced scientists based across five laboratory locations including Berlin, London, Cape Town, Turku (Finland) and Rockville, Maryland (USA). Priding ourselves as a leading player at the forefront of our industry we have recently acquired Syrinx Bioanalytical group to enhance our offering and provide our customers with a broader range of services, deeper scientific expertise, a wider set of analytical platforms across an expanded geographical footprint. Over the coming years, Synexa aims to continue to grow, both organically and through acquisitions, to ensure we can meet the needs of our expanding customer base while becoming the leading global specialist in biomarker and bioanalytical solutions for the clinical trial industry.

At GoGood, we work towards developing a reuse economy for office furniture that will be preferred to the consumer economy. Our solution consists of a digital reuse-platform that aims to become a driving force in the reuse economy for used office furniture. We have taken a concrete approach, starting with office interiors as our initial focus. In Norway alone, the office furniture market is worth over 4 billion annually, yet we discard 140,000 tons of furniture valued at 400-500 million Norwegian kroner each year. This cannot continue. That's why we have developed a reuse-platform for furniture, including a marketplace for the professional furniture market, making it incredibly easy for businesses, interior architects, and other stakeholders to sell their furniture while also simplifying the process of purchasing used furniture for interior projects, as well as making old furniture look new again. Over the past two years, we have made significant progress in developing modern reuse solutions, products, and services. With public support totaling over 15 million Norwegian kroner from the Research Council of Norway, Innovation Norway, and the Oslo municipality, as well as partnerships with industry players such as Flokk, Aarsland, Ope, Norsk Gjenvinning, Glomma Industrier, Hannah Nordh, Oslo Waste and Recycling Agency, NORSUS - Norwegian Institute for Sustainability Research, Norsk Regnesentral, and OBOS, we are now ready with our reuse-platform making the circular economy for office furniture on a large scale possible-

AquaFood has a patent-pending method for extracting high-value, food-grade components at cold temperatures from the side streams of fish production (e.g. heads, backbone, scales, etc.). The components we extract are; pure fish oil that fits as a supplement, a unique protein mass with high functionality (almost minced meat consistency) that fits perfectly for fish balls, fish burgers, or even tubed fish spread, and lastly, we extract a fine collagen powder that fits for dermatological applications. Today, the side streams of fish production account for 40-70% of the fish that is brought into the processing plants. This is a remarkably higher amount than any other food-producing industry. At the same time, the food production system worldwide accounts for 1/3 of green-house gas emissions, 1/3 of land usage, and 2/3 of groundwater withdrawal. The seafood industry has problems of their own, where 95% of our fish stocks are fully utilized and about 30% have already collapsed. There simply is not way for us to increase or even continue to produce the way that we are in a sustainable way. But we still need to increase food production as the globally increasing population will demand a doubling of protein production in the year 2050 compared to now. AquaFood believes that resource efficiency is a huge stepping stone toward reaching a sustainable food production system. A system where we use our resources efficiently and to their full potential is what needs to happen to step into a sustainable future. In our process, we can make sure that the FULL fish is used to its full potential. Through our process, we use no heating steps and the only effluents from our process are the water that we introduce to the system mixed with a small amount of protein. Therefore, our process is highly efficient, sustainable in terms of lower energy and water consumption but also in terms of the resource efficiency that it brings. Our technology is research-based and stems from decades of research in the area of utilization of aquatic biomasses.